Successful Treatment of Pediatric Alopecia Areata of the Scalp Using Topical Bimatoprost

Pediatric Dermatology

Volumn 33, Issue 5, 2016, Pages e282-e283

  Li, Alvin W ^a   Antaya, Richard J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; CLOBETASOL; MINOXIDIL; TRIAMCINOLONE ACETONIDE;

ALOPECIA AREATA; ARTICLE; CASE REPORT; CHILD; CHILDHOOD DISEASE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HAIR GROWTH; HAIR LOSS; HUMAN; PRIORITY JOURNAL; SCALP HAIR; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84985994512     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12920     Document Type: Article

References (4)

1. Messenger AG, McKillop J, Farrant P et al. British Association of Dermatologists’ guidelines for the management of alopecia areata 2012. Br J Dermatol 2012;166:916–926.
2. Tosti A, Pazzaglia M, Voudouris S et al. Hypertrichosis of the eyelashes caused by bimatoprost. J Am Acad Dermatol 2004;51:S149–S150.
3. Tauchi M, Fuchs TA, Kellenberger AJ et al. Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost. Br J Dermatol 2010;162:1186–1197.
4. Zaher H, Gawdat HI, Hegazy RA et al. Bimatoprost versus mometasone furoate in the treatment of scalp alopecia areata: a pilot study. Dermatology 2015;230:308–313.